P526: REAL-WORLD COMPARISON OF DIFFERENT TREATMENT MODALITIES FOR FAVORABLE RISK ACUTE MYELOID LEUKEMIA: STANDARD DOSE ANTHRACYCLINE VS HIGH DOSE ANTHRACYCLINE VS ADDITION OF GEMTUZUMAB OZOGAMICIN

• J. Mort,
• B. Brewer,
• B. Mautner,
• S. Dibenedetto,
• E. Pierce,
• E. Morse,
• L. Wells,
• F. Ghamsari,
• A. Morris,
• S. Clark,
• J. Reid,
• I. Patel,
• C. Jackson,
• M. Perciavalle,
• B. Yelvington,
• R. Miller,
• K. Abernathy,
• H. Wolfe,
• S. Locke,
• J. Zeidner,
• D. Reed,
• V. Duong,
• B. Dholaria,
• T. LeBlanc,
• M. Keng,
• B. Horton,
• F. El Chaer

Affiliations

J. Mort

1 Hematology and Oncology

B. Brewer

2 Public Health Sciences, Division of Translational Research and Applied Statistics, University of Virginia, Charlottesville

B. Mautner

1 Hematology and Oncology

S. Dibenedetto

1 Hematology and Oncology

E. Pierce

1 Hematology and Oncology

E. Morse

1 Hematology and Oncology

L. Wells

1 Hematology and Oncology

F. Ghamsari

1 Hematology and Oncology

A. Morris

1 Hematology and Oncology

S. Clark

3 Hematology and Oncology, University of North Carolina, Chapel Hill

J. Reid

3 Hematology and Oncology, University of North Carolina, Chapel Hill

I. Patel

4 Hematology and Oncology, University of Maryland Medical Center, Baltimore

C. Jackson

5 Hematology and Oncology, Wake Forest Baptist Medical Comprehensive Cancer Center, Winston-Salem

M. Perciavalle

6 Hematology and Oncology, Vanderbilt University Medical Center, Nashville

B. Yelvington

6 Hematology and Oncology, Vanderbilt University Medical Center, Nashville

R. Miller

6 Hematology and Oncology, Vanderbilt University Medical Center, Nashville

K. Abernathy

6 Hematology and Oncology, Vanderbilt University Medical Center, Nashville

H. Wolfe

7 Hematology and Oncology, Duke Cancer Institute, Durham, United States of America

S. Locke

7 Hematology and Oncology, Duke Cancer Institute, Durham, United States of America

J. Zeidner

3 Hematology and Oncology, University of North Carolina, Chapel Hill

D. Reed

5 Hematology and Oncology, Wake Forest Baptist Medical Comprehensive Cancer Center, Winston-Salem

V. Duong

4 Hematology and Oncology, University of Maryland Medical Center, Baltimore

B. Dholaria

6 Hematology and Oncology, Vanderbilt University Medical Center, Nashville

T. LeBlanc

7 Hematology and Oncology, Duke Cancer Institute, Durham, United States of America

M. Keng

1 Hematology and Oncology

B. Horton

2 Public Health Sciences, Division of Translational Research and Applied Statistics, University of Virginia, Charlottesville

F. El Chaer

1 Hematology and Oncology